Clinical Trial Update: R(+)XK469 in Treating Patients With Advanced Neuroblastoma [Phase 1]

View source ↗

Summary

A Phase 1 trial of R(+)-XK469 in patients with advanced neuroblastoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroblastoma

Drugs mentioned

• R(+)XK469 (R(+)-XK469)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Disseminated Neuroblastoma, Localized Unresectable Neuroblastoma | Phase 1 | Status: COMPLETED